Cigna Group $CI Shares Sold by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC cut its stake in Cigna Group (NYSE:CIFree Report) by 11.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,736 shares of the health services provider’s stock after selling 225 shares during the period. Premier Path Wealth Partners LLC’s holdings in Cigna Group were worth $574,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Flaharty Asset Management LLC bought a new position in shares of Cigna Group in the first quarter worth $28,000. 1248 Management LLC bought a new position in shares of Cigna Group in the first quarter worth $29,000. Solstein Capital LLC bought a new position in shares of Cigna Group in the second quarter worth $29,000. Activest Wealth Management grew its stake in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC bought a new position in shares of Cigna Group in the second quarter worth $30,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on CI shares. Truist Financial set a $375.00 price target on Cigna Group in a research note on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Cantor Fitzgerald restated an “overweight” rating and set a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday, October 8th. Finally, Wolfe Research reduced their target price on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and a consensus price target of $369.89.

View Our Latest Stock Analysis on Cigna Group

Cigna Group Stock Down 17.4%

Shares of Cigna Group stock opened at $247.11 on Friday. Cigna Group has a 1 year low of $245.61 and a 1 year high of $350.00. The stock has a 50-day moving average price of $298.38 and a 200 day moving average price of $306.70. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a market cap of $65.96 billion, a P/E ratio of 13.49, a P/E/G ratio of 0.88 and a beta of 0.45.

Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter in the prior year, the business earned $7.51 earnings per share. The company’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.